17-allyl-amino-seldanamycin induces HER2 degradation and AKT inactivation in a human breast cancer xenograft model Meeting Abstract
| Authors: | Solit, D.; Munster, P.; Basso, A.; Tong, W.; Agus, D.; Scher, H.; Norton, L.; Rosen, N. |
| Abstract Title: | 17-allyl-amino-seldanamycin induces HER2 degradation and AKT inactivation in a human breast cancer xenograft model |
| Meeting Title: | 11th Annual NCI-EORTC-AACR Symposium on New Drugs in Cancer Therapy |
| Journal Title: | Clinical Cancer Research |
| Volume: | 6 |
| Issue: | Suppl. |
| Meeting Dates: | 2000 Nov 7-10 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2000-01-01 |
| Start Page: | 4545s |
| Language: | English |
| ACCESSION: | WOS:000165409000354 |
| PROVIDER: | wos |
| PUBMED: | 11145548 |
| Notes: | Meeting Abstract: 396 -- Source: Wos |
